Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620746 · ClinicalTrials.gov registry record · Phase 4
Penicillin Allergy Testing in STD Clinics
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 284
- Enrollment target
NCT04620746: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT04620746 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 284 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04620746, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 284 participants
- Enrollment target
Study Summary
Demonstration project to implement penicillin allergy testing in STD outpatients using a questionnaire and pen allergy testing
Primary Outcome
Used yes/no questionnaire designed by study team. Any positive response on the high-risk history was grounds for exclusion from randomization to allergy testing arm
Interventions
- DRUG Penicillin Major Determinant (PrePen) Skin Testing
- DRUG Direct Oral challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 4 |
What the finished NCT04620746 record still lists
NCT04620746 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Penicillin Major Determinant (PrePen) Skin Testing is the first listed.
NCT04620746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04620746 about?
NCT04620746 is a clinical study titled "Penicillin Allergy Testing in STD Clinics". Demonstration project to implement penicillin allergy testing in STD outpatients using a questionnaire and pen allergy testing
What is the current status of trial NCT04620746?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 284 participants. The study started on 2021-06-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04620746?
The interventions under investigation include: Penicillin Major Determinant (PrePen) Skin Testing (DRUG), Direct Oral challenge (DRUG).
Who is sponsoring clinical trial NCT04620746?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04620746's enrollment target sits among peer trials
284 302nd of 2000 higher than 1,698 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI